Back to Feed
ClinicalTrials.gov|Clinical Trial
CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)
Beijing GoBroad Hospital
Abstract
A Clinical Study Exploring CT1190B in the treatment of patients with moderate to severe refractory systemic lupus erythematosus (SLE) or refractory/progressive systemic sclerosis (SSc) Phase: PHASE1 Status: RECRUITING Conditions: Systemic Lupus Erythematosus (SLE); Systemic Sclerosis (SSc) Interventions: CAR-T Therapy
Keywords
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)